Atara Biotherapeutics, Inc.ATRANASDAQ
Loading
Operating cash flow minus capital expenditures
Latest
$-50.94M
↑ 69% vs avg
Percentile
P69
Within normal range
Streak
3 yr
Consecutive growthExpanding
Average
$-163.29M
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| TTM | $-50.94M | +26.1% |
| 2024 | $-68.96M | +64.5% |
| 2023 | $-194.20M | +29.3% |
| 2022 | $-274.62M | -18.8% |
| 2021 | $-231.10M | -24.7% |
| 2020 | $-185.27M | +23.2% |
| 2019 | $-241.36M | -11.9% |
| 2018 | $-215.70M | -100.2% |
| 2017 | $-107.73M | -70.9% |
| 2016 | $-63.05M | - |